Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors

Surgery (United States)

Volumn 154, Issue 4, 2013, Pages 785-793

  Cherenfant, Jovenel ^a   Stocker, Susan J ^a   Gage, Mistry K ^a   Du, Hongyan ^a   Thurow, Tiffany A ^a   Odeleye, Melanie ^d   Schimpke, Scott W ^e   Kaul, Karen L ^a   Hall, Curtis R ^a   Lamzabi, Ihab ^e   Gattuso, Paolo ^e   Winchester, David J ^a   Marsh, Robert W ^a   Roggin, Kevin K ^d   Bentrem, David J ^b,c   Baker, Marshall S ^a   Prinz, Richard A ^a   Talamonti, Mark S ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Jesse Brown Medical Center   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CAUCASIAN; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN TISSUE; ICD-9; INCIDENTAL FINDING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PERINEURAL INVASION; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RACE; RISK FACTOR; SURVIVAL; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84884827929     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.07.004     Document Type: Article

References (21)

1. S.L. Asa Pancreatic endocrine tumors Modern Pathol 24 2011 566 577
2. K.Y. Bilimoria, J.S. Tomlinson, R.P. Merkow, A.K. Stewart, C.Y. Ko, and M.S. Talamonti Clinicopathologic features and treatment trends in pancreatic neuroendocrine tumors: analysis of 9821 patients J Gastrointest Surg 11 2007 1460 1469
3. S. Ekeblad, B. Skogseid, and K. Dunder Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution Clin Cancer Res 14 2008 7798 7803
4. P.A. Vagefi, O. Razo, V. Deshpande, D.J. McGrath, G.Y. Lauwers, and S.P. Thayer Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005 Arch Surg 142 2007 347 354
5. L.C. Lee, C.S. Grant, and M. Huebner Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): Role for nonoperative management Surgery 152 2012 965 974
6. A.B. Haynes, V. Deshpande, T. Ingkakul, P.A. Vagefi, J. Szymonifka, and S.P. Thayer Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes Arch Surg 146 2011 534 538
7. K.K. Kazanjian, H.A. Reber, and O.J. Hines Resection of pancreatic neuroendocrine tumors: results of 70 cases Arch Surg 141 2006 765 769
8. S.N. Hochwald, S. Zee, K.C. Conlon, R. Colleoni, O. Louie, and M.F. Brennan Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups J Clin Oncol 20 2002 2633 2642
9. G.Q. Phan, C.J. Yeo, H.R. Hruban, K.D. Lillemoe, H.A. Pitt, and J.L. Cameron Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients J Gastrointest 2 1998 473 482
10. P. Tomassetti, D. Campana, L. Piscitelli, R. Casadei, D. Santini, and F. Nori Endocrine pancreatic tumors: factors correlated with survival Ann Oncol 16 2005 1806 1810
11. C. Gao, X. Fu, Y. Pan, and Q. Li Surgical treatment of pancreatic neuroendocrine tumors: report of 112 cases Dig Surg 27 2010 197 204
12. P.J. Hodul, J.R. Strosberg, and L.K. Kvols Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated? Cancer Control 15 2008 314 321
13. J.S. Hill, J.T. McPhee, T.P. McDade, Z. Zhou, M.E. Sullivan, and G.F. Whalen Pancreatic neuroendocrine tumors: the impact of surgical resection on survival Cancer 115 2009 741 751
14. P. Hellman, M. Andersson, J. Rastad, C. Juhlin, S. Karacagil, and B. Eriksson Surgical strategy for large or malignant endocrine pancreatic tumors World J Surg 24 2000 1353 1360
15. V. Fendrich, P. Langer, I. Celik, D.K. Bartsch, A. Zielke, and A. Ramaswamy An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors Ann Surg 244 2006 845 851
16. R.M. Minter, and D.M. Simeone Contemporary management of nonfunctioning pancreatic neuroendocrine tumors J Gastrointest Surg 16 2012 435 446
17. K.Y. Bilimoria, M.S. Talamonti, and D.J. Bentrem Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients Ann Surg 247 2008 490 500
18. F. Sellner, S. Thalhammer, S. Stattner, J. Karner, and M. Klimfinger TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas-a single-institution experience J Surg Oncol 104 2011 17 21
19. J.R. Parekh, S.C. Wang, E.K. Bergsland, A.P. Venook, R.S. Warren, and G.E. Kim Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients Pancreas 41 2012 840 844
20. D. Chatterjee, M.H. Katz, A. Rashid, H. Wang, A.C. Iuga, and G.R. Varadhachary Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma Am J Surg Pathol 36 2012 409 417
21. J.W. Chen, M. Bhandari, D.S. Astill, T.G. Wilson, L. Kow, and M. Brooke-Smith Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion HPB (Oxford) 12 2010 101 108